EPISODE · Jul 8, 2024 · 12 MIN
ASCO 2024 Plenary: ADRIATIC Trial in Limited Stage Small Cell Lung Cancer
from Two Onc Docs
This week’s episode will discuss updates from ASCO 2024 next with the practice changing ADRIATIC trial presented by Dr. Spigel during the plenary: Durvalumab as consolidation treatment for patients with limited-stage small-cell lung cancer (LS-SCLC).
Embed this episode
NOW PLAYING
ASCO 2024 Plenary: ADRIATIC Trial in Limited Stage Small Cell Lung Cancer
0:00
12:26
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Two Onc Docs?
This episode is 12 minutes long.
When was this Two Onc Docs episode published?
This episode was published on July 8, 2024.
Can I download this Two Onc Docs episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!